News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
220,620 Results
Type
Article (4974)
Company Profile (22)
Press Release (215624)
Section
Business (82180)
Career Advice (460)
Deals (15038)
Drug Delivery (8)
Drug Development (19051)
Employer Resources (30)
FDA (3672)
Job Trends (3894)
News (120068)
Policy (7497)
Tag
Academia (291)
Alliances (14685)
Alzheimer's disease (212)
Approvals (3666)
Bankruptcy (94)
Best Places to Work (2829)
Biotechnology (24)
Breast cancer (21)
Cancer (201)
Career advice (391)
Cell therapy (44)
Clinical research (15593)
Collaboration (69)
Compensation (58)
COVID-19 (292)
C-suite (31)
Data (216)
Diagnostics (1986)
Earnings (39576)
Employer resources (31)
Events (36759)
Executive appointments (106)
FDA (3764)
Funding (67)
Gene therapy (22)
GLP-1 (94)
Government (404)
Healthcare (4997)
Infectious disease (301)
Inflammatory bowel disease (21)
Interviews (53)
IPO (7726)
Job creations (1119)
Job search strategy (360)
Layoffs (95)
Legal (2321)
Lung cancer (23)
Manufacturing (24)
Medical device (3811)
Medtech (3812)
Mergers & acquisitions (7331)
Metabolic disorders (56)
Neuroscience (249)
NextGen Class of 2024 (1672)
Non-profit (722)
Northern California (420)
Obesity (31)
Opinion (28)
People (24095)
Phase I (4639)
Phase II (6774)
Phase III (5386)
Pipeline (105)
Postmarket research (625)
Preclinical (1820)
Press Release (66)
Radiopharmaceuticals (103)
Rare diseases (30)
Real estate (1868)
Regulatory (4968)
Research institute (298)
Resumes & cover letters (68)
Southern California (308)
Startups (1005)
United States (3509)
Vaccines (24)
Date
Today (54)
Last 7 days (266)
Last 30 days (797)
Last 365 days (11245)
2024 (9454)
2023 (13193)
2022 (18659)
2021 (19681)
2020 (18240)
2019 (13208)
2018 (10205)
2017 (10004)
2016 (9158)
2015 (12119)
2014 (9587)
2013 (7707)
2012 (8329)
2011 (8796)
2010 (8634)
Location
Africa (182)
Arizona (47)
Asia (11257)
Australia (1548)
California (841)
Canada (407)
China (24)
Colorado (32)
Connecticut (43)
Europe (23861)
Florida (110)
Georgia (18)
Idaho (23)
Illinois (69)
Indiana (33)
Japan (23)
Kansas (23)
Maine (32)
Maryland (114)
Massachusetts (729)
Michigan (55)
Minnesota (95)
Montana (16)
New Jersey (282)
New York (260)
North Carolina (224)
Northern California (420)
Ohio (32)
Pennsylvania (185)
South America (273)
Southern California (308)
Texas (97)
Utah (24)
Washington State (84)
220,620 Results for "glaukos corporation".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Biotech Beach
Glaukos Announces Participation in Upcoming Investor Conferences - May 28, 2024
Glaukos Corporation today announced that its management is scheduled to participate in the following upcoming investor conferences.
May 28, 2024
·
1 min read
Press Releases
Glaukos Announces Third Quarter 2024 Financial Results
November 4, 2024
·
16 min read
Press Releases
Ripple Therapeutics Announces Evaluation and Licensing Agreements with Glaukos
October 15, 2024
·
2 min read
Business
Glaukos Announces First Quarter 2024 Financial Results
Glaukos Corporation (NYSE: GKOS), an ophthalmic pharmaceutical and medical technology company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, today announced financial results for the first quarter ended March 31, 2024.
May 1, 2024
·
14 min read
Biotech Beach
Glaukos Announces Agreements to Exchange $230 Million in Principal Amount of Its 2.75% Convertible Senior Notes Due 2027 for Common Stock
Glaukos Corporation, an ophthalmic pharmaceutical and medical technology company, announced that it entered into separate, privately negotiated exchange agreements with certain holders of its 2.75% Convertible Senior Notes due 2027.
June 14, 2024
·
5 min read
Business
Glaukos to Release First Quarter 2024 Financial Results after Market Close on May 1
Glaukos Corporation plans to release first quarter 2024 financial results after the market close on Wednesday, May 1, 2024.
April 10, 2024
·
1 min read
Press Releases
Glaukos To Present Multiple Scientific Abstracts at the 2024 American Academy of Ophthalmology Annual Meeting
October 14, 2024
·
8 min read
Press Releases
Glaukos to Release Third Quarter 2024 Financial Results after Market Close on November 4
October 9, 2024
·
1 min read
Business
Stuart Therapeutics Announces Exclusive Worldwide License Agreement with Glaukos Corporation
Stuart Therapeutics, Inc. (“Stuart”) today announced that it has entered into a license agreement with Glaukos Corporation (“Glaukos”) under which it has granted Glaukos exclusive worldwide rights to develop and commercialize Stuart’s proprietary ST-113 drug candidate for neuroprotection in glaucoma.
October 18, 2023
·
3 min read
Biotech Beach
Glaukos To Present Numerous Scientific Abstracts at the 2024 American Society of Cataract and Refractive Surgery Annual Meeting
Glaukos Corporation announced today that it will present multiple scientific abstracts at the American Society of Cataract and Refractive Surgery (ASCRS) annual meeting, being held April 5-8, 2024 in Boston, MA.
April 1, 2024
·
9 min read
1 of 22,062
Next
